Open AccessOne Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates
Author(s) -
P. W. Denton,
F. Othieno,
F. Martinez-Torres,
W. Zou,
J. F. Krisko,
E. Fleming,
S. Zein,
D. A. Powell,
A. Wahl,
Y. T. Kwak,
B. D. Welch,
M. S. Kay,
D. A. Payne,
P. Gallay,
E. Appella,
J. D. Estes,
M. Lu,
J. V. Garcia
Publication year - 2011
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/2675-ah14
Subject(s) - tenofovir , human immunodeficiency virus (hiv) , medicine , immunology